FISCHERNSEFischer Medical Ventures LimitedMediumNeutral
Announced Wed, 8 Apr · 15:59 IST

SHANKAR VARADHARAJAN has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Ownership Changes View source PDF

FISCHER · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-0.4%1-day move
₹41.00
prior close
₹41.79
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.7-1.1-1.1-1.8-0.4-1.3+0.2-0.4+0.0-5.0-7.5-11.1-23.7-7.1
Up moveDown movePending
AI summary

Shankar Varadharajan, promoter of Fischer Medical Ventures Limited, has submitted a nil disclosure under Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 for the financial year ended 31st March 2026. The disclosure confirms that neither he nor the promoter group (which includes FMV Holdings Pte Ltd, Singapore, and Mr. Ravindran Govindan as persons acting in concert) have created any new share encumbrances during the year, beyond what has already been disclosed to the stock exchanges. This is a routine negative declaration filing to comply with SEBI regulations requiring annual confirmation of no fresh pledging or encumbrances by promoters.

Likely market impact

A nil declaration is neutral to positive for investors as it confirms no fresh pledging of promoter shares has occurred during the year, reducing risk of forced selling. The promoter group's shareholding structure remains unchanged as previously disclosed.